Fresenius Medical Care AG (FMS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	19.5B	19.6B	19.3B	19.5B	19.4B
Cost of Revenue	14.3B	14.6B	14.6B	14.5B	14.5B
Gross Profit	5.2B	5.0B	4.8B	4.9B	4.9B
Operating Expenses
R&D Expense	158.0M	158.0M	183.5M	232.0M	228.6M
SG&A Expense	3.0B	3.0B	3.1B	3.2B	3.2B
General & Admin Expense	2.7B	2.4B	2.5B	2.5B	2.4B
Selling & Marketing Expense	360.6M	618.1M	660.4M	706.4M	800.9M
Other Expenses	217.1M	11.4M	(37.0M)	127.3M	(17.1M)
Total Operating Expenses	3.4B	3.2B	3.3B	3.6B	3.4B
Cost and Expenses	17.7B	17.8B	17.9B	18.1B	17.9B
Operating Income (EBIT)	1.8B	1.8B	1.5B	1.4B	1.5B
Non-Operating
Interest Income	59.0M	69.6M	71.6M	88.2M	67.7M
Interest Expense	387.4M	384.4M	407.0M	424.6M	360.1M
Net Interest Income	(328.4M)	(314.8M)	(335.5M)	(336.4M)	(292.5M)
Other Non-Op Income/Expense	(363.4M)	(314.6M)	(410.5M)	(336.4M)	(292.5M)
Non-Operating Income (excl Interest)	(9.3M)	(69.8M)	3.4M	(88.2M)	(67.7M)
EBT (Pre-Tax Income)	1.4B	1.5B	1.1B	1.0B	1.2B
Income Tax Expense	316.9M	321.0M	316.1M	300.6M	325.0M
Bottom Line
Net Income	822.8M	978.4M	537.9M	499.0M	673.4M
Earnings from Cont. Ops	1.1B	1.2B	740.9M	732.5M	894.3M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	822.8M	978.4M	537.9M	499.0M	673.4M
Per Share
Basic EPS	$1.51	$1.68	$0.92	$0.85	$0.57
Diluted EPS	$1.51	$1.68	$0.92	$0.85	$0.57
Revenue Per Share	$37.04	$33.70	$32.95	$33.15	$16.54
Shares
Basic Shares Outstanding	525.9M	582.4M	586.8M	586.8M	1.2B
Diluted Shares Outstanding	524.0M	582.4M	586.8M	586.8M	1.2B
Profitability Metrics
EBITDA	3.0B	3.4B	3.2B	3.2B	3.4B
D&A	1.2B	1.5B	1.7B	1.8B	1.8B
EBIT	1.8B	1.9B	1.5B	1.5B	1.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026